
MHP Adrenaline Drive 30 Tablets

MHP Adrenaline Drive is a sublingual tablet that dissolves in your mouth giving you instant energy, focus, and increased performance anytime day or night. These tasty min flavored tablets give you quick and long lasting energy anytime you need it.
For maximum results, place one Fastsorb tablet in your mouth and allow tablet to dissolve completely (for at least 2-5 minutes) before chewing and then swallowing. Do not exceed 2 tablets in a 12 hour period of time.
Serving Size: 1 Fastsorb Tablet
Servings Per Container: 30
Calories 5
Total Carbohydrate 2g
Riboflavin 0.5mg
Vitamin B6 (as pyridoxine HCL) 0.6mg
Vitamin B12 (as cyanocobalamin) 2.4mcg
Adrenaline Drive Instant Energy Blend
Caffeine (from caffeine anydrous and yerba mate leaf extract) 150mg
Yerbe Mate Leaf 4:1 ext (llex parajuariensis) (20% Theophyline) 75mg
Mucuna Pruriens (seed) extract (60% L-Dopa) 43mg
Huperzine A (from Huperzia Serrata Whole Plant Extract) 25mcg
*% Daily Value is based on a 2,000 calorie diet. Your daily values may be higher or lower based on your calorie needs.
*Daily Value Not Established
Ingredients: Sorbitol, Stearic Acid, Natural Flavors, MOdifid Cellulose, Sucralose, Medium Chain Triglycerides (MCT) Oil Powder, Menthol Crystals, Magnesium Stearate, Silica and FD&C Blue #1 Lake.
This product is strictly intended for use by healthy persons 18 years of age or older. Contains 150mg caffeine per serving. Caffeine intake is not advisable in cases of high blood pressure, heart problems, pregnancy or nursing. Do not combine with use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness and occasionally rapid heartbeat. Do not exceed recommended dose. For adult use only.
Cappelletti S, Piacentino D, Sani G, Aromatario M. Caffeine: cognitive and physical performance enhancer or psychoactive drug? [published correction appears in Curr Neuropharmacol. 2015;13(4):554. Daria, Piacentino [corrected to Piacentino, Daria]]. Curr Neuropharmacol. 2015;13(1):71-88. doi:10.2174/1570159X13666141210215655